FDA Wants Triad Group to Halt Production

The Food and Drug Administration has asked Triad Group to stop producing and distributing its products, including alcohol prep wipes, povidone iodine prep wipes and lubricating jelly which are all suspected of bacterial contamination and have recently been recalled.

The alcohol wipes, recalled in January for potential contamination with the bacteria Bacillus cereus, have been blamed for the death of a 2-year-old boy in Houston as well as several serious infections.

Becillus cereus is an organism which can cause life-threatening skin infections.  The infections are especially dangerous in at risk populations, including immune suppressed and surgical patients.  In some case, the infections can lead to death.

Messa & Associates has handled dozens of cases involving drugs and medical devices.  Our have successfully pursued litigation and obtained verdicts and settlements for victims of suffering from these injuries.  If you or a loved one has contracted a skin infection or other injury as a result of a Triad Group product, please contact us at 1-877-MessaLaw.

More Johnson & Johnson Recalls

Johnson & Johnson has issued a recall for more than 700,000 bottles or packages of Tylenol and other consumer medicines.  J&J's McNeil Consumer Healthcare unit recalled one lot of Tylenol 8 Hour Extended Release Caplets, or 34,056 bottles, from retailers, citing a musty odor like the one that has prompted many other J&J recalls.

           

The odor is thought to be caused by trace amounts of a chemical used to treat wooden pallets on which bottles are stored and shipped.  Some people have experienced nausea, vomiting, stomach pain, or diarrhea.

McNeil added 10 lots of other products, amounting to 717,696 bottles or packages, to a wholesale level recall it initiated in January.  Those products include various forms of pain reliever Tylenol, as well as allergy drug Benadryl and cough/cold medicine Sudafed.

The drugs were manufactured at a Fort Washington, Pa. plant that is now closed.  In the past 15 months, Johnson & Johnson has recalled more than 300 million bottles and packages of adult and children's consumer medicines.

The attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries.  Our skilled team of attorneys has successfully pursued litigation and obtained verdicts and settlements for victims of pharmaceutical injuries.  If you or a loved one is suffering from serious injuries as a result of this or any other Johnson & Johnson recall, please contact us at 1-877-MessaLaw.

Possible Mislabeling Leads to Drug Recall

Pfizer Inc's Greenstone LLC is recalling two of its drugs, Citalopram and Finasteride, because the bottles may have been labeled incorrectly.

The company says bottles of Citalopram, a depression drug, may have been labeled inaccurately as Finasteride, used to treat benign prostatic hyperplasia, and vice versa.  Finasteride is dangerous to pregnant women due to risks of side effects that can cause fetal abnormalities to the external genitalia of a developing male fetus.  Citalopram patients who discontinue Citalopram abruptly by inadvertently taking the mislabeled product may experience discontinuation symptoms and/or worsening of depression.

The recalled bottles of Citalopram and Finasteride are marked with lot number FI0510058-A on the label.

The attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries.  Our extremely skilled team of attorneys and medical experts has successfully pursued litigation and obtained verdicts and settlements for victims of pharmaceutical injuries.  If you or a loved one is suffering from serious injuries as a result of ingesting drugs from the mislabeled bottles of Citalopram and Finasteride, please contact us at 1-877-MessaLaw.